Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Ingredients
Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients.

Week Of March 8, 2010: Company And People Notes: Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

March 11, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

Week Of March 1, 2010: Company And People Notes: Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

March 4, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

Skinny or Dead

March 2, 2010

Pharmaceutical Technology

If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.

Consumers Need Access to Lower-Cost Biogenerics

March 2, 2010

Pharmaceutical Technology

To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.

Navigating the Global Pharmaceutical Supply Chain

March 2, 2010

Pharmaceutical Technology

Emerging markets remain an important element in the strategies of pharmaceutical companies and their suppliers.

Spherical Crystallization for Lean Solid-Dose Manufacturing (Part 1)

March 2, 2010

Pharmaceutical Technology

In Part I of this article, the authors describe the materials and methods used in developing a screening strategy to accelerate the preparation and characterization of spherical agglomerates by spherical crystallization.

Industry Pipeline

March 2, 2010
Pharmaceutical Technology

Pre-Interphex 2010 Product Releases.

Opportunities in the Biosimilars Market

March 2, 2010

Pharmaceutical Technology

Analysis of the opportunities and challenges in the biosimilars market.

Report from India

March 2, 2010

Pharmaceutical Technology

Could President Obama's tax reform, which is tareted at reducing outsourcing, endanger India's contract-services industry?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
18%
In Western Europe
19%
In Central and Eastern Europe
3%
In Japan
2%
In India
30%
In China
29%
View Results
Jim MillerOutsourcing OutlookJim Miller Time for a Model Upgrade
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Navigating the Global Pharmaceutical Supply Chain
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Click here